题名

川崎氏症青少年之心肺功能及運動能力探討

并列篇名

A Study on Cardiopulmonary Function and Exercise Capacity of Adolescents Suffered from Kawasaki Disease in Childhood

DOI

10.6202/THJ-2015-11-06

作者

賴家欣(Chia-Hsin Lai);林克隆(Ko-Long Lin);方進隆(Chin-Lung Fang)

关键词

急性血管炎 ; 身體活動 ; 心肺適能 ; Acute systemic vasculitis ; Physical activity ; Cardiopulmonary fitness

期刊名称

慈惠學報

卷期/出版年月

11期(2015 / 12 / 01)

页次

62 - 72

内容语文

繁體中文

中文摘要

川崎氏症(Kawasaki disease, KD)最早由日本川崎富作醫師於1967年針對患者症狀進行臨床觀察研究而提出,目前仍無特定的診斷測試或疾病特有的臨床特徵,因此診斷上以臨床症狀為準則。心血管的影響是川崎氏症急性期的重要議題,目前相關探討患者運動表現的研究較少,本研究目的是為了瞭解兒童時期罹患川崎氏症的青少年其心肺功能及運動能力與一般青少年之間的差異。本研究針對40名心室中膈缺損青少年及40名一般青少年進行心肺功能及運動能力測試。測試結果顯示在心肺功能部分,兒童時期罹患川崎氏症青少年的用力肺活量與第一秒用力吐氣容積和對照組比較皆無顯著差異,且第一秒用力吐氣容積與用力肺活量的比值及最大自主通氣量方面和對照組也無明顯差異。此外,研究組在運動時的最大心跳數與對照組相比較小,但兩組在最大攝氧量及最大收縮壓部分並無顯著差異。本研究的數據顯示,兒童時期罹患川崎氏症青少年的心肺功能與一般青少年比較並無較差的狀況,因此不會造成在運動上的限制。另外在運動時最大心跳表現部分,研究組表現比一般青少年差,其原因可能是因全身性血管炎造成的內皮受損導致成長後心血管病變。對川崎氏症患者而言,長期的心血管觀察是重要的議題,但運動可改善冠狀動脈患者的運動耐力及週邊血管的內皮功能。因此我們建議川崎氏症的患者應該注意避免造成動脈硬化的危險因子,努力維持健康、控制飲食、維持運動以促進心肺功能及生活品質。

英文摘要

Kawasaki Disease (KD) is an acute systemic vasculitis which was first found in 1967 in Japan. The diagnosis of typical or incomplete KD is based on clinical criteria. The clinical features, especially cardiac complications are the leading causes of childhood acquired heart disease. There were only a small number of reviews related to exercise performance on KD. Therefore, cardiopulmonary function and exercise capacity in adolescents post-KD were evaluated through this study. Maximal anaerobic capacity as well as factors of restrictive exercise capacity were evaluated in the study. A cardiopulmonary exercise stress assessment was performed upon 40 adolescents post-KD among the experimental group along with 40 healthy adolescents in the control group. Based on the finding, no significant differences were found in maximal systolic blood pressure and maximum heart rate but VO2 max. Pulmonary function tests also showed no significant differences in forced vital capacity (FVC), forced vital capacity second (FEV1), ventilation (MVV), nor FEV1/FVC. In the presented study, adolescents post-KD showed normal cardiopulmonary function and exercise capacity comparing to those from the healthy group; no limitations in exercise were observed additionally. Thus keep average exercise to maintain quality of life was suggested.

主题分类 醫藥衛生 > 預防保健與衛生學
醫藥衛生 > 社會醫學
参考文献
  1. American College of Sports Medicine(2006).ACSM’s guidelines for exercise testing and prescription.Baltimore, MD:Lippincott Williams & Wilkins.
  2. Brogan, P.A.,Bose, A.,Burgner, D.,Shingadia, D.,Tulloh, R.,Michie, C.(2002).Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research.Archives of Disease in Childhood,86(4),286-290.
  3. Castello-Simões, V.,Minatel, V.,Karsten, M.,Simões, R. P.,Perseguini, N. M.,Milan, J. C.(2015).Circulatory and ventilatory power: Characterization in patients with coronary artery disease.Arquivos Brasileiros de Cardiologia,104(6),476-485.
  4. Chen, S.,Dong, Y.,Yin, Y.,Krucoff, M. W.(2013).Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: A meta-analysis.Heart,99(2),76-82.
  5. Clarke, L. A.,Hong, Y.,Eleftheriou, D.,Shah, V.,Arrigoni, F.,Klein, N. J.(2010).Endothelial injury and repair in systemic vasculitis of the young.Arthritis & Rheumatology,62(6),1770-1780.
  6. Conraads, V. M.,Pattyn, N.,De Maeyer, C,Beckers, P. J.,Coeckelberghs, E.,Cornelissen, V. A.(2015).Aerobic interval training and continuous training equally improve aerobic exercise capacity in patients with coronary artery disease: the SAINTEX-CAD study.International Journal of Cardiology,20(179),203-210.
  7. Dietz, S.M.,Tacke, C. E.,Gort, J.,Kuipers, I. M.,de Groot, E.,Wiegman, A.(2015).Carotid intima-media thickness in patients with a history of Kawasaki disease.Circulation Journal
  8. Fukazawa, R.,Ogawa, S.(2009).Long-term prognosis of patients with Kawasaki disease: at risk for future atherosclerosis?.Journal of Nippon Medical School,76(3),124-33.
  9. Gersony, W. M.(2009).The adult after Kawasaki disease the risks for late coronary events.Journal of the American College of Cardiology,54(21),1921-1923.
  10. Holman, R. C.,Curns, A. T.,Belay, E. D.,Steiner, C. A.,Schonberger, L. B.(2003).Kawasaki syndrome hospitalizations in the United States, 1997 and 2000..Pediatrics,112,495-501.
  11. Huang, S. K.,Lin, M. T.,Chen, H. C.,Huang, S. C.,Wu, M. H.(2013).Epidemiology of Kawasaki disease: prevalence from national database and future trends projection by system dynamics modeling.Journal of Pediatrics,163(1),126-131.
  12. Huang, W. C.,Huang, L. M.,Chang, I. S.,Chang, L. Y.,Chiang, B. L.,Chen, P.J.(2009).Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006.Pediatrics,123(3),e401-e405.
  13. Kato, H.,Akagi, T.,Sugimura, T.,Sato, N.,Kazue, T.,Hashino, K.(1995).Kawasaki disease.Coronary Artery Disease,6,194-206.
  14. Kato, H.,Sugimura, T.,Akagi, T.,Sato, N.,Hashino, K..,Maeno, Y.(1996).Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients.Circulation,94,1379-1385.
  15. Liu, Y.,Onouchi, Z.,Sakata, L.,Ikuta, K.(1996).An experimental study on the role of smooth muscle cells in the pathogenesis of atherosclerosis of the corornary arteritis.Nippon Shonika Gakkai Zasshi,100,1453-1458.
  16. Miller, M. R.,Hankinson, J.,Brusasco, V.,Burgos, F.,Casaburi, R.,Coates, A.(2005).Standardisation of spirometry.European Respiratory Journal,26,319-338.
  17. Nakamura, Y.,Yashiro, M.,Uehara, R.,Sadakane, A.,Tsuboi, S.,Aoyama, Y.(2012).Epidemiologic features of Kawasaki disease in Japan: Results of the 2009–2010 nationwide survey.Journal of Epidemiology,22,216-221.
  18. Newburger, J. W.,Takahashi, M.,Gerber, M. A.,Gewitz, M. H.,Tani, L. Y.,Burns, J. C.(2004).Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.Pediatrics,114(6),1708-1733.
  19. Park, Y. W.,Han, J. W.,Hong, Y. M.,Ma, J. S.,Cha, S. H.,Kwon, T. C.(2010).Epidemiological features of Kawasaki disease in Korea, 2006–2008.Pediatrics International,53,36-39.
  20. Rowley, A. H,Shulman, S.T.(2010).Recent advances in the understanding and management of kawasaki disease.Current Infectious Disease Reports,12,96-102.
  21. Shah, V.,Christov, G.,Mukasa, T.,Brogan, K. S.,Wade, A.,Eleftheriou, D.(2015).Cardiovascular status after Kawasaki disease in the UK.Heart,101(20),1646-1645.
  22. Shulman, S. T.,Inocencio, J.,Hirsch, R.(1995).Kawasaki disease.Pediatric Clinics of North America,42,1205-1222.
  23. Terai, M.,Shulman, S.T.(1997).Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose.Journal of Pediatrics,131(6),888-893.
  24. Tobayama, H.,Takahashi, K.,Fukunaga, H.,Matsui, K.,Tanaka, N.,Harada, M.(2013).Analysis of arterial function in adults with a history of Kawasaki disease.Journal of Cardiology,61(5),330-335.
  25. Uehara, R.,Belay, E. D.(2012).Epidemiology of Kawasaki disease in Asia, Europe, and the United States.Journal of Epidemiology,22,79-85.
  26. Wood, L.,Tulloh, R.(2007).Kawasaki disease: diagnosis, management and cardiac sequelae.Expert Review of Cardiovascular Therapy,5,553-561.
  27. Woywodt, A.,Streiber, F.,de Groot, K.,Regelsberger, H.,Haller, H.,Haubitz, M.(2003).Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis.Lancet,361(9353),206-210.
  28. Yoshikawa, J.,Yanagihara K.,Owaki, T.,Kato, H.,Takagi, Y.,Okumachi, F.(1979).Cross-sectional echocardiographic diagnosis of coronary artery aneurysms in patients with the mucocutaneous lymph node syndrome.Circulation,59,133-139.
  29. 鴻樟(1999)。1999國科會與環保署科技合作研究計畫期末報告書1999國科會與環保署科技合作研究計畫期末報告書,臺北市:國立臺灣大學公共衛生學院環境衛生研究所。